Bought
Maintained
Sold
Other funds holding LIVN
Axa's LIVN Position: Q2 2025 in Review
Axa sold out of LivaNova (LIVN) in Q2 2025, closing a stake of 40,579 shares — an estimated $1.59M sold.
Axa first reported a position in LIVN in Q1 2016 and held it in 14 quarters. The position peaked at $4.13M in Q2 2023. 252 funds tracked by Wall St. Rank hold LIVN as of Q2 2025.
- Axa reported no remaining LivaNova position as of Q2 2025 after selling out during the quarter.
- Axa sold 40,579 LivaNova shares in Q2 2025, an estimated $1.59M.
- Axa first reported a position in LivaNova in Q1 2016 and held it in 14 quarters.
- Axa's LivaNova position peaked at $4.13M in Q2 2023.
- 252 funds tracked by Wall St. Rank held LivaNova as of Q2 2025.
Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.